* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Oral mucosal lesions caused by infective microorganisms I. Viruses
African trypanosomiasis wikipedia , lookup
Anaerobic infection wikipedia , lookup
Hepatitis C wikipedia , lookup
Sarcocystis wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
West Nile fever wikipedia , lookup
Schistosomiasis wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Neonatal infection wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Marburg virus disease wikipedia , lookup
Henipavirus wikipedia , lookup
Herpes simplex wikipedia , lookup
Oesophagostomum wikipedia , lookup
Hepatitis B wikipedia , lookup
Herpes simplex virus wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Coavrinht 0 Munksgaard I999 Periodontology 2000, Voi. 21, 1999, 106-124 Printed in Denmark All rights reserved PERIODONTOLOGY 2000 ISSN 0906-6713 Oral mucosal lesions caused by infective microorganisms I. Viruses and bacteria - FRANCISCO RIVERA-HIDALGO & THOMAS W. STANFORD The purpose of this chapter is to concisely review oral lesions that are caused by viruses and bacteria infecting the oral tissues. In this context we adhere to the classical concept of infection: the state of injury or damage that results from the process by which organisms, capable of causing disease, gain entry to the body and establish colonies.a Oral lesions may originate from local infections or may represent the oral manifestations or consequences of a systemic infection. The oral mucosal environment is characterized by the presence of a large complex microbiota that, under normal circumstances, does not cause pathosis. The health status of the mouth is largely the result of a balance resulting from the interaction between microorganisms and the local defensive mechanisms, and thus, any changes that may alter this interaction may lead to disease. Factors that may alter this balance include changes in the integrity of the epithelium, changes in lubrication of the mucosa and changes in secretion of saliva. This oral environmental balance might also be altered by changes in the systemic defensive posture that result from a compromised immune system. When the defensive system is temporarily weakened by stress, smoking and poor oral hygiene, diseases such as acute necrotizing ulcerative gingivitis can ensue. Normal microbiota microorganisms can become opportunistic pathogens in an altered oral environment. Lesions of infective origin may affect any of the oral mucosal structures: the masticatory mucosa, the lining mucosa and the specialized mucosa. The term infective stomatitis, used as an inclusive term, is preferred to group these lesions. For the purpose of this Modified from: Collins dictionary of medicine. Glasgow, Harper Collins. I06 review, the lesions of infective stomatitis are categorized according to the type of microorganism causing the infection. The literature reports on bacterial stomatitis, fungal stomatitis, parasitic stomatitis and viral stomatitis. This chapter presents reviews of viruses and bacteria. Part I1 presents reviews of fungi and parasites. Incidence of infective stomatitis Infective stomatitis is infrequently observed in the healthy individual, but there exists an impression of an overall increase in incidence during the past few years due to increased incidence rates of tuberculosis (189) and syphilis (55). There have also been reports of an increased incidence of opportunistic oral infections (3) and other types of oral infections (99), especially in human immunodeficiency virus (HIV)-positivepatients. One may speculate that the ever-increasing use of antibiotics, an expanding population of immunosuppressed individuals and a more mobile global society are factors that have contributed to the rise in the incidence of oral infections. By far, immunosuppression represents the major contributing factor. With the appearance of HIV disease, many of the previously rare diseases have reappeared and sometimes with a different presentation. The development of molecular biology techniques and better understanding of immune mechanisms have contributed significantly in the detection of previously unrecognized pathogens in a disease process. This is particularly true for virally induced diseases. It is with this background that we review the literature for oral infectious diseases. Oral mucosal lesions caused bv infectiue microorganisms. I. Viruses and bacteria Table 1. Oral viral infections Infection ~- Causative virus Strains or other names or acronyms Measles Measles virus Mumps Mumps virus Hand, foot and mouth disease Herpanaina Coxsackievirus Coxsackievirus (A5, A10, A16) (A2-6,A10) Primary herpetic gingivostomatitis Recurrent intraoral herpes Recurrent herpes labialis Herpes simplex type 1 (HSV-1) or type 2 virus HSV-1, HSV-2 HSV-1, HSV-2 (HHV-1, HHV-2) (HHV-1, HHV-2) Varicella (chickenpox1 Shingles Infectious mononucleosis Hairy leukoplakia Varicella-zoster virus Varicella-zoster virus Epstein-Barr virus Epstein-Barr virus (HHV-3) (HHV-3) (HHV-4) (HHV-4) (HHV-5) a Roseola (exanthema subitum)" Heterophil-negative infectious mononucleosis Human herpesvirus 6 (HHV-6) Kaposi's sarcoma Kaposi's sarcoma herpesvirus (HHV-8) Oral lesions have not been reported: this is included from completion. High proportions of oral squamous carcinoma lesions have been shown to be positive for HHV-6. A recent report supports a role for HHV-7 in pityriasis rosea. Infective stomatitis: infections caused by viruses Oral lesions secondary to viral infections are relatively common during an individual's lifetime. Diseases of the infancy and childhood such as measles and mumps are caused by an RNA virus (paramyxoviridae) and may present oral lesions. Coxsackieviruses, a subgroup of the RNA enteroviruses, cause herpangina and hand, foot and mouth diseases, which present oral lesions. Oral papillomas, oral verrucous carcinoma and focal epithelial hyperplasia are caused by a DNA virus (human papillomavirus of the papovavirus family). Oral lesions are also produced by the human herpesvirus family, which are DNA viruses. Viruses belonging to the herpes family are major pathogens in oral disease. A summary of oral viral infections appears in Table 1. Paramyxoviridae Paramyxoviridae is a family of RNA viruses composed of three genera: Paramyxovirus, Morbillivirus and Pneumovirus. Measles. An enveloped RNA virus that belongs to the Morbillivirus genus causes measles (rubeola) (8, 74). This virus, which was first isolated in cultures in 1954, preferentially infects monocytes. Measles is a highly communicable disease transmitted by inhalation of infective droplets with an incubation period of 10 to 14 days. Measles remains a major cause of childhood mortality in developing countries (36). Measles is one of a group of vaccine-preventable diseases in which vaccination programs have greatly reduced its incidence. It is an acute systemic condition with a prodrome in which the patient suffers from cough, conjunctivitis, fever, photophobia, rhinitis and Kopliks spots. Kopliks spots, the bluish-gray specks on a red base, are pathognomonic for measles, as they appear approximately 48 hours before the irregular red-brick maculopapular skin rash. Kopliks spots appear on the mucosa next to the molar teeth and may last for 4 days. Shedding of the measles virus starts during the prodromal stage and continues through the acute stage. A recent report has shown that laboratory confirmation of measles is possible using oral fluids for the detection of measles-specific immunoglobulin M (IgM) (76). In a recent report, cases originally diagnosed as measles or rubella (German measles) were later diagnosed as primary herpesvirus 6 and herpesvirus 7 infections (181. Mumps. Mumps (epidemic parotiditis) (8, 74) is caused by the mumps virus, an RNA virus that be- 107 Rivera-Hidalgo& Stanford longs to the Paramyxovirus genus. Parotid salivary gland infection may occur unilaterally or bilaterally, and viremia can lead to orchitis, aseptic meningitis, pancreatitis and oophoritis, especially in unvaccinated individuals. Affected salivary glands may be swollen and painful and may be accompanied by erythema and swelling of the parotid (Stensen’s) duct. Mumps is a highly communicable disease transmitted by inhalation of infective droplets with an incubation period of 14 to 21 days. Similar to measles, the disease is one of a group of vaccinepreventable diseases, and vaccination programs have greatly reduced its incidence. Picornaviridae Picornaviridae is a family of single-stranded nonenveloped RNA viruses composed of three genera: Enterovirus, Poliovirus and Rhinovirus. The Enterovirus genus includes the coxsackievirus (A and B), echoviruses, enteroviruses and poliovirus (types 1, 2 and 3). Coxsackieviruses. Coxsackieviruses are antigenically divided into groups A and B comprising more than 50 serotypes. Infections are more common during the summer months and are transmitted by contaminated aerosol (74). Many of these viruses can cause oropharyngeal vesiculoulcerative lesions and are clinically differentiated by the location of the lesions (47). These viruses are responsible for hand, foot and mouth disease, herpangina, lymphonodular pharyngitis and ulcerative oropharyngitis, all producing oral lesions. Lymphonodular pharyngitis features orange slightly painful papules in the soft palate while ulcerative pharyngitis produces ulcerations in the soft palate, lips and buccal mucosa (47). Hand, foot and mouth disease. Hand, foot and mouth disease can be caused by coxsackieviruses A5, A10 and, most commonly, by A16. It is a disease of children with an incubation period of 3 to 5 days, but the disease has been reported in adults as well (97). The lesions appear as ulcerations on buccal mucosa (rhomboidal vesicles “square blisters” (162)) and soft palate, often in conjunction with ulcers on the hands and feet. In the largest reported epidemic in England and Wales during 1994, most of 950 cases were children 1-4 years of age and disease severity was associated with the degree of mouth lesions (14). Treatment with acyclovir has been reported to be effective (162). The disease is benign and resolves in 7 to 10 days. 108 Herpangina. Herpangina is caused by coxsackieviruses A2, A3, A4, A5, A6 and A10. It features clustered petechiae in the soft palate that become shallow ulcers in a few days and then heal. Headache, high fever, myalgia and sore throat precede soft palate lesions. Treatment is palliative. Papovaviridae Papovaviridae are a family of DNA viruses that are responsible for producing tumors and capable of transforming animal cell lines. The family is composed of the Papillomavirus genus and the Polyomavirus genus. Papillomavirus. The human papillomavirus is composed of more than 60 serological types (39). Papillomaviruses cause lesions in many areas of the body, including genitalia, the nasal cavity, larynx, trachea, esophagus and the mouth. Diagnosis of papillomavirus lesions is made based on the histopathological appearance. Characteristic features include koilocytosis, acanthosis and papillomatosis which, coupled to the clinical appearance, suggest the infection (39). The classical oral lesions associated with human papillomavirus are squamous cell papilloma (58, 143, 182), condyloma acuminatum (58, 1431, verruca vulgaris (58, 143) and focal epithelial hyperplasia (58, 143). Squamous cell papilloma is a cauliflower-like lesion with a narrow base. It is a small, pink exophytic growth of the oral mucosa. The lesion of condyloma acuminatum is similar, presenting multiple small, soft, pale lesions with a cauliflower-like surface. Histologically, both lesions have the same appearance, and human papillomavirus types 6 and 11 are involved (135, 197). Treatment is by surgical excision. Verruca vulgaris or the common wart is a narrow exophytic growth, wider at the base, sessile and firm. The lesion is usually found on the gingiva, labial mucosa, commissure, hard palate or tongue (113, 135, 137). Human papillomavirus types 2 and 57 have been identified in the lesions (125, 135). Treatment is by surgical excision. Focal epithelial hyperplasia (Heck‘s disease) usually presents as multiple plaque-like or papular lesions, flat or convex, in the mucosa mostly of children (34). The color may vary from red to gray to white (135). Lesions occur on oral mucosa exclusively (135). There may be a genetic predisposition, and contrary to the initial reports, the condition is not limited to certain ethnic groups (136). The Oral mucosal lesions caused by infective microorganisms. I. Viruses and bacteria lesions are benign and may resolve spontaneously. Human papillomavirus types 13 and 32 have been implicated as causative agents (124, 135). Other oral lesions (135) that have been associated with human papillomavirus include erythroplakia (HPV-16), proliferative verrucous leukoplakia (HPV16) (1261, candidal leukoplakia (1881, oral squamous cell carcinoma (HPV-16 and HPV-19) (9, 109, 135, 188) and lichen planus (HPV-6, HPV-11 and HPV-16) (87, 135, 179). Overall, HPV types 2, 4, 6, 11, 13 and 32 have been associated with benign oral lesions while HPV types 16 and 18 have been associated with malignant lesions (58). Transmission of the virus can occur with direct contact and from mother to child during delivery (138). Herpetoviridae The Herpetoviridue family contains only one genus: Herpesvirus. Viruses of the herpes family are doublestranded DNA viruses transmitted from host to host by direct contact with saliva or genital secretions, where they are shed by asymptomatic hosts (67). The herpes viruses are classified into three groups (30). The alpha group (subfamilyAlphuherpesvirinue) includes the herpes simplex virus 1 (HSV-l),the herpes simplex virus 2 (HSV-2) and the varicellazoster virus. The beta group (subfamily Betuherpesvirinae) includes the human cytomegalovirus, while the gamma group (subfamily Gummuherpesvirinae) includes the Epstein-Barr virus. The species names and the acronyms of herpes viruses used in the literature are as follows: human herpesvirus 1 (HSV11, human herpesvirus 2 (HSV-21, human herpesvirus 3 (varicellazoster virus), human herpesvirus 4 (Epstein-Barr virus), human herpesvirus 5 (human cytomegalovirus), human herpesvirus 6 (HHV-61, human herpesvirus 7 (HHV-7)and human herpesvirus 8 (HHV-8 or Kaposi’s sarcoma herpesvirus). Herpesviruses cause a primary infection after which they remain latent within the host’s cells for the life of the individual. While latent, the virus may become reactivated and may cause symptomatic or asymptomatic recurrent infection (160). Factors that may trigger reactivation of the virus include trauma, stress, immunosuppression, immune dysfunction and radiotherapy (22, 123). Latency is maintained (67) for HSV-1, HSV-2 and varicellazoster virus in sensory nerve ganglia; Epstein-Barr virus in B lymphocytes and salivary gland tissue (1131, human cytomegalovirus in lymphocytes and salivary gland tissue, HHV-6 in mononuclear cells in ductal epithelium (192), HHV-7 in salivary gland tissue primarily the submandibular gland (153) and HHV-8 in salivary gland tissue (102). It has been proposed that the clinical patterns of reactivation of HSV-1, HSV-2 and varicellazoster virus are different (170). Herpes simplex virus types 1 and 2. The primary infection with herpes simplex virus usually occurs in infants or children and may cause a prodrome of fever, malaise and nausea. The infection may go unnoticed, be subclinical or produce pharyngitis (67). Usually, the infection presents vesicles on the mucosa of the mouth and pharynx that break to produce ulcers. A generalized marginal gingivitis may occur in conjunction with ulcers in the alveolar mucosa and gingiva, and crusting of the lips is a common feature. Lesions can occur extraorally, while systemic symptoms usually include fever and chills. This primary herpetic gingivostomatitis is usually accompanied by cervical lymphadenopathy, and it may be more severe when it occurs in adults (47). Disseminated herpes simplex virus infections have been reported with a flu-like prodrome and a severe generalized outbreak of vesiculo-ulcerative lesions. The disseminated herpes simplex virus infection can occur during pregnancy, and infants born during the course of such infection have a high mortality rate (196). After the primary infection, the virus goes dormant in the sensory and autonomic trigeminal or sacral ganglia to be reactivated by certain conditions. Latent infection exists when the viral genome is present in the tissue without production of infective viral particles (169). Recurrent infections affect 20% to 40% of individuals after the primary infection (67). Recurrent infections with type 1herpes simplex virus are classically described as occurring above the waist, whereas type 2 infections occur below the waist, but either can appear in the other region. There is regional preference of reactivation for each virus; type 1 virus appears to arise more frequently from the trigeminal ganglia, affecting the oral cavity, whereas type 2 is most often reactivated from the sacral ganglia, producing genital lesions (195). The typical appearance of intraoral recurrent lesions (recurrent intraoral herpes) is of a cluster of small ulcers in the attached gingiva. The initially discrete and usually painful ulcers may coalesce to form larger lesions that heal in 10 to 12 days. In HIV-positive patients and other immunocompromised individuals, atypically deep and large ulcers may occur that persist for weeks to months. Herpes labialis (cold sores) is a common expression of recurrent herpes infection. Lesions may affect the lips and perioral skin as a result of triggering of 109 Rivera-Hidalgo & Stanford a latent ganglion infection, usually by ultraviolet radiation (96), other local stimuli, fever, emotional stress or menstruation (169). Lesions appear as closely clustered vesicles that tend to reappear in the same area with each outbreak (170). It is interesting to note that, even after repeated infection, there appears to be no sensory loss in the area (65). Trigeminal neuralgia has been described in conjunction with episodes of herpes labialis, suggesting that the neuro-sensory abnormalities may be induced by reactivation of herpes simplex virus (65). In addition, herpetic reactions may sometimes trigger unilateral or bilateral facial paralysis (herpetic facial paralysis), which may be identical to Bell’s palsy (157). Herpetic infection of the fingers (herpetic Whitlow) can induce painful locally severe lesions in which surgical intervention may lead to spread of the virus and is thus contraindicated (89, 90). Herpetic Whitlow was an occupational hazard for dental professionals prior to initiation of universal infection control measures such as gloving for all patient care in dental practice. Acyclovir has been recommended in treatment of the various forms of recurrent HSV1 and HSV-2 infections, but the drug appears more predictably successful in the management of genital herpes as opposed to oral lesions. Oral lesions are quite responsive to acyclovir, however, in immunocompromised individuals (147). In HIV-positive patients, herpes simplex virus has been recovered from persistent oral ulcers in more than 30% of cases (48). In another report, cultures from 40 HIV-positive patients with persistent oral ulcers yielded herpes simplex virus in 19% of the cases, cytomegalovirus in 53% and coinfection of herpes simplex virus and cytomegalovirus in 28% (53). In this study, treatment with systemic ganciclovir in conjunction with oral acyclovir resulted in lesion resolution in all but one case. Diagnosis of herpes simplex virus from lesions can be made using cultures, which take up to 10 days, or by using enzyme-linked immunosorbent assay (961, polymerase chain reaction (65, 169) or direct immunofluorescence. Cultures are more predictably diagnostic if obtained from an early vesicular lesion rather than an ulcer. Varicella zoster virus (HHV-3). The varicella zoster virus causes varicella (chickenpox) as a primary infection mainly in children and later, in adults, its reactivation causes herpes zoster (shingles). Varicella is a highly infectious disease transmitted by inhalation of infective droplets and by direct contact with lesions. It is self-limiting in children and more severe 110 in adults. The pruritic skin rash progresses through macules, papules, vesicles, drying vesicles and scabs, with healing occurring over 2 to 3 weeks. Oral lesions include vesicles on the lips, hard palate and soft palate (113). After the primary infection, the virus remains latent in the dorsal root ganglion (it is not clear whether it resides in neurons or in satellite cells (156)) to be reactivated later. Herpes zoster results from reactivation of the latent virus. Fever and malaise may accompany the appearance of lesions. Vesicles quickly break to form ulcerated lesions with prominent red borders, resembling apthae. Lesions are unilaterally distributed along the infected nerve (113). Paresthesia, pain and tenderness are the initial symptoms of herpes zoster, which may appear prodromally 3-5 days before the lesions (67).The infection is more frequent in elderly individuals, and it has been suggested that shingles may signal the presence of systemic disease. When reactivation occurs from the trigeminal ganglion, there seems to be a preference for the second or third divisions (67). It is not known what induces reactivation, but alterations in cell-mediated immunity have been implicated (91). In most patients, the infection is self-limiting. Antiviral agents (acyclovir, valacyclovir and famciclovir (67, 130))are effective in reducing the course of the disease in varicella and in reducing the effects of secondary infections. Antiviral agents should be used as early as possible in disease development (113). Prolonged postherpetic neuralgia is a common aftermath of herpes zoster (118).It is hypothesized that the neuralgia results from virally induced lesions in the neurons (145).Necrosis of alveolar bone followed by tooth exfoliation has been described as a complication of intraoral herpes zoster (118). In immunocompromised individuals, including those with HIV, there is increased incidence and recurrence (170) of herpes zoster infection. Chronic varicella occurs in HIV-positive patients and is an atypical persistent form of the disease. Treatment with intravenous acyclovir and foscarnet has been effective in controlling the infection (27). Clinical presentation and occurrence of complications of virus reactivation are related to degree of immunodeficiency (178). Epstein-Barr virus (HHV-4). The Epstein-Barr virus is transmitted by blood or saliva. Primary infection can occur at any age. It is often subclinical in children. Epstein-Barr virus can cause infectious mononucleosis in adolescents and young adults. The symptoms of infectious mononucleosis in- Oral mucosal lesions caused by infective microorganisnu. I. Viruses and bacteria clude fever, lymphadenopathy (especially the posterior cervical chain), malaise and sore throat (pharyngitis). Oral ulcers, multiple palatal petechia and infrequently gingival ulcerations have been reported (67, 113). Diagnostic tests for heterophile antibodies produced by Epstein-Barr virus are available (Monospot test). The disease is self-limiting, requiring bed rest and analgesics, with recovery usually occurring in about 4 weeks. Acyclovir has not been effective in treatment. Occasionally, a latent infection of Epstein-Barr virus can be reactivated, leading to viral shedding into the oral mucosa. It has been hypothesized that constant shedding can lead to infection of epithelial cells, and this may explain the appearance of oral hairy leukoplakia in HIV-positive patients (82). Oral hairy leukoplakia was first described in HIVpositive homosexual men (69). Clinically, it presents as a white lesion most often on the ventral-lateral surface of the tongue that can be unilateral or bilateral (156). Lesions have a corrugated appearance with keratin projections that look like hair. The histological features include parakeratosis with hair-like projections, hyperplasia, acanthosis and koilocytelike cells within the epithelium and an absence of inflammation in the connective tissue (156).Langerhans cells are also absent (37).There is evidence that Epstein-Barr virus replicates within epithelial cells (70). The appearance of oral hairy leukoplakia in HIV-positive patients may be highly predictive of the development of AIDS (71). Reports indicate, however, that in some cases, oral hairy leukoplakia can appear in the absence of HIV, and oral hairy leukoplakia has been reported in patients who are not immunosuppressed (102, 113). Additionally, there are reports of lesions similar to oral hairy leukoplakia in cases that were Epstein-Barr virus negative (66, 111). Epstein-Barr virus has also been found in malignancies (nasopharyngeal carcinoma, Burkitt’s lymphoma, B-cell lymphoma (67) and oral squamous cell carcinoma (52)) and in periodontal disease (35), although its role in periodontal disease has not been determined. Human cytomegalovirus (HHV-5). Human cytomegalovirus is found in many of the body secretions (including blood, milk and saliva) of infected individuals. However, it is one of the least prevalent herpesvirus infections (113). Most primary infections are asymptomatic, and it is not clear where the virus remains latent, although it is recoverable from 25% of salivary glands (74). Endothelial and ductal epithelial cells seem to be a tar- get for human cytomegalovirus (86). Antibody to human cytomegalovirus is present in the serum of most homosexual men (74). Human cytomegalovirus infection produces three recognizable clinical syndromes (74): perinatal disease and human cytornegalovirus inclusion disease, acute acquired human cytoinegalovirus infection and human cytomegalovirus disease in immunocompromised hosts. Perinatal disease is the result of a primary infection while the mother is pregnant. The infection may affect the fetus, causing severe consequences. When the infection is acquired neonatally, it resembles infectious mononucleosis or it may be asymptomatic. The second syndrome is similar to infectious mononucleosis except that there is no (or milder) pharyngitis associated and no production of heterophil antibodies. The third syndrome is observed in immunocompromised individuals, tissue and bone marrow transplant patients, and in HIV-infected patients. Human cytomegalovirus infection in these patients is in itself immunosuppressive and can worsen HIV opportunistic infections. Oral lesions in patients infected with human cytomegalovirus occur in the latter two syndromes. The most common manifestation of primary infection is heterophil-negative infectious mononucleosis (1131, which occurs in adults (113). Infection can result from sexual contact and blood transfusions (67).The disease follows a course similar to that seen with Epstein-Barr virus infection and is self-limiting. Oral ulcerations related to human cytomegalovirus have been described in immunodepressed patients (53, 86, 141). It has been reported that, in a group of HIV-positive patients, more than half (53%) of persistent ulcers were associated with human cytomegalovirus, and another 28% were associated with human cytomegalovirus and herpes simplex virus coinfection (53).Tissue biopsies of suspected human cytomegalovirus-induced oral ulcers can be diagnosed by a combination of histological and immuno cytochemical met hods (53).Treatment with a combination of oral acyclovir and systemic ganciclovir has proved successful (53). Human herpesvirus 6 (HHV-6). The originally named human B-lymphotropic virus (154) has recently been reclassified as a herpesvirus and renamed HHV-6 (168). In infants, this virus is associated with roseola (exanthema subitum or sixth disease), a self-limiting condition that causes a mild skin exanthem and fever (1). HHV-6 is commonly isolated from saliva (in mononuclear cells in ductal 111 Rivera-Hidalgo & Stanford epithelium) and has affinity for CD4 lymphocytes (192). It is also suspected of causing mononucleosis, pneumonia, meningitis, encephalitis and as a cofactor in accelerated immunosuppression in HIV-infected individuals. Infection with HHV-6 can induce the expression of CD4 on CD8+ cells (lymphocytes and natural killer cells), thus rendering them susceptible to infection by HIV-1 (106). It is believed that HHV-6 is responsible for short-lived febrile illnesses and active hepatitis in previously healthy individuals as well as prolonged febrile illness in patients that are immunodeficient (168). Two variants have been identified, A and B (94). The B variant is sensitive to ganciclovir, and both are sensitive to foscarnet (74). There are instances where infectious mononucleosis cannot be associated with either Epstein-Barr virus or human cytomegalovirus infection. There is evidence that HHV-6 is responsible for some of these infections, although is not clear whether these represent primary infections or reactivation of latent virus (168). There is also evidence that both H W - 6 and Epstein-Barr virus, as coinfectants, are responsible for some acute infectious mononucleosis (17). HHV-6 has been found in oral squamous carcinoma lesions (191, 192) and in cervical carcinoma (191). In a study of 51 squamous cell carcinomas, 18 non-malignant lesions and 7 normal mucosa samples, HHV-6 was found in 79% of malignancies, 67% of lichen planus lesions and leukoplakia and was not present in normal mucosa (193). In this study, HHV-6 variant B was found in 60% of the malignancies. Human herpesvirus 7 (HHV-7). HHV-7 is a ubiquitous virus, that is very similar to HHV-6 in that it has serological cross-reactivity with some antibodies to HHV-6 (102). Infection is usually acquired in childhood with most adults being seropositive. The virus is found in saliva and is secreted for many years after initial infection (173). Saliva represents the major mode of transmission, and transmission has been detected from a grandparent to a parent to a child (173). In general, initial infection occurs later in life than with HHV-6 infection. Minor labial salivary glands have been shown to harbor the virus, and these glands may sometimes be the sites where replication occurs (193). In a study of more than 100 specimens from the three salivary glands, HHV-7 was found in 100% of submandibular gland samples, 85% of the parotid gland samples and in 59% of lip minor salivary gland samples (153). HHV-7 has been reported to enhance the cytotoxicity of natural killer cells through induction of interleukin 15 (5). 112 HHV-7 appears to be associated with at least two conditions: roseola and pityriasis rosea. Patients recovering from roseola were found to have sera positive to both HHV-6 and HHV-7, suggesting a role for both viruses in the disease (120). Patients with pityriasis rosea showed HHV-7 DNA in plasma, supporting a role for viral replication and virulence (42). Pityriasis rosea is a self-limiting exanthem without systemic signs or symptoms characterized by crops of maculopapular pale-red oval lesions on skin that may last for up to 2 weeks (60). Oral lesions of the tongue and cheek have been reported in pityriasis rosea (180). There is evidence that infections misdiagnosed as measles and rubella could be caused by primary infections of HHV-6 or HHV-7 (18). Human herpesvirus 8 (HHV-8). Newly discovered, the human herpesvirus 8 is believed to be associated with the pathogenesis of human lymphomas (22, 30). Originally, the virus was called Kaposi’s sarcoma herpesvirus and was later renamed HHV-8 (57, 93). HHV-8 DNA sequences have been identified in body cavity-based non-Hodgkin’s lymphomas, Castleman’s disease, angioimmunoblastic lymphadenopathy and all forms of Kaposi’s sarcoma (102, 105). Serological evidence indicates that HHV-8 is found in 25% of the adult population and in up to 8% of children in the United States (100). It is also evident that women with AIDS are much less likely to develop Kaposi’s sarcoma than men (63). Kaposi’s sarcoma was originally described as a rare vascular malignant tumor occurring in elderly men of mainly Mediterranean, eastern European or Middle Eastern origin. The tumor has become more prevalent with the advent of the AIDS epidemic, although it has been reported in the skin of an HIVnegative immunosuppressed patient with bullous pemphigoid (59). These reports suggest that immunosuppression may serve to activate a latent HHV-8 infection. In one study, HHV-8 DNA sequences were identified in 53 of 54 AIDS related oral Kaposi’s sarcoma lesions (54). Palliative treatment of the oral lesions has been reported using an intralesional injection of vinblastine (46). Infective stomatitis: infections caused by bacteria Bacterial infective stomatitis has been reported in both immunocompetent and immunocompromised patients. Some of these infections can become es- Oral mucosal lesions caused bv infective microornanisms. I. Viruses and bacteria tablished as a result of transmission during sexual activity; others result from a weakening in the host’s defense posture and are thus opportunistic in nature. In these section we review the reported bacterial infections that can present oral lesions. A summary of oral bacterial infections and responsible organisms appears in Table 2. Acute necrotizing ulcerative stomatitis Acute necrotizing ulcerative gingivitis (or necrotizing gingivostomatitis or necrotizing ulcerative gingivitis) is an acute infection of the gingiva that has been known by different names through the years (78). Because of its prevalence in the soldiers fighting in the trenches during World War I, it was called trench mouth; because of a description of the microorganisms in the lesions by Vincent, it was also called Vincent’s infection. Vincent’s angina refers to an infection of the tonsils and pharynx usually associated with acute necrotizing ulcerative gingivitis. Likewise, noma or cancrum oris or gangrenous stomatitis is often an extension of acute necrotizing ulcerative gingivitis into the adjacent tissues. Noma is at best disfiguring and can be lethal if not treated promptly. In recent years, the disease has become a common cause of mortality and disability in children of underdeveloped areas of Africa, Asia and South America (2, 38, 174). Noma has been reported in patients with HW, where local removal of necrotic tissue along with lavage with providone-iodine has been effective in controlling the disease (31). Acute necrotizing ulcerative gingivitis is an infec- tious disease of the gingiva causing gingival bleeding, gingival ulceration (that may lead to the loss of the tissue forming the papilla) and pain. It has been reported more commonly in young adults, although recently it has been reported with increasing frequency in children in developing countries. Factors that may predispose to the initiation of this disease include episodes of stress, smoking, malnutrition and poor oral hygiene (80). These factors suggest that, given the condition where poor oral hygiene exists, events that can depress the host’s immune response can precipitate the disease. A mixed flora of spirochetes (Treportema spp.), fusobacteria (Fusobacterium n u c l e a t u m ) , Preuotella intermedia, Veillonella spp. and streptococci and have been implicated in the disease. Early attempts to induce the disease by the subcutaneous injection of cultures from active patients have only produced abscesses and not the disease (150). From the lesions created, Fusobacterium fusiforme and Borwlia irincentii (a spirochete) can be recovered. However, later work showed that the spirochete found in the lesion was not B. vincentii (104). Listgarten showed spirochetes infiltrating healthy tissue ahead of the lesion. Other bacteria and viruses have been found associated to the lesions, but no cause-effect relationship has been established (116). Acute necrotizing ulcerative gingivitis has been reported in recent years in patients with HIV infection or AIDS. Acute necrotizing ulcerative gingivitis has been included in a classification of periodontal diseases associated with HIV infection (43, 112). 1he classification includes: linear gingival erythema, nec- Table 2. Oral bacterial infections Infection Causative bacteria Mixed bacterial flora including spirochetes and Fusobacteria ~ Acute necrotizing ulcerative gingivitis (necrotizing ulcerative gingivitis, necrotizing gingivostomatitis,necrotizing stomatitis, noma (cancrum oris), Vincent’s infection, trench mouth) __ Actinomycosis ~~ Actinomyces israelii Actinomyces viscosus Actinomyces odontolyticus Actinomyces naeslundii Bartonella quintana BaronteZlu henselae __ _ _ _ _ _ _ _ _ Neisseria gonorrhoeae Bacillary angiomatosis (epithelioid angiomatosis) __ - Gonorrhea ~~ .- __ ~ Streptococcal stomatitis ______ ~ . __. ~~ ~~~ ~~~~ ~ ~~~ ~ ~ ~~ Mycobacterium tuberculosis Mycobacterium leprae rium avium and intracellulare rium bovis rium chelonae Mycobacterium-kansasii Streptococci Group A beta-hemolytic streptococci ~. ~~~~ 113 Rivera-Hidalgo & Stanford ~~~ rotizing ulcerative gingivitis and necrotizing ulcerative periodontitis. In this classification acute necrotizing ulcerative gingivitis is described as destruction of one or more gingival papilla, with ulceration, cratering and necrosis. In a study of naval personnel, Horning & Cohen reported that acute necrotizing ulcerative gingivitis cases in seropositive and in seronegative HIV cases were clinically indistinguishable (80). Necrotizing ulcerative periodontitis is described as producing very rapid bone loss in addition to the findings for acute necrotizing ulcerative gingivitis (116). Severe deep aching pain with a very rapid rate of bone destruction is characteristic of necrotizing ulcerative periodontitis. It is believed by some that necrotizing ulcerative periodontitis is an extension of acute necrotizing ulcerative gingivitis.Acute necrotizing ulcerative gingivitis and necrotizing ulcerative periodontitis have been correlated with decreased CD4 counts (<200/mm3). Glick et al. (62) reported that HIV-seropositive individuals presenting with necrotizing ulcerative periodontitis were 20.8 times (odds ratio) more likely to have CD4 counts below 200 cells/mm? compared with HIV-seropositive individuals without necrotizing ulcerative periodontitis. In this study, the predictive value of a CD4 count below 200 cells/mm3 in patients with necrotizing ulcerative periodontitis was 95%. Further, the cumulative probability of death within 24 months of a necrotizing ulcerative periodontitis diagnosis was 73%. Necrotizing ulcerative periodontitis can extend into the alveolar mucosa and adjacent tissues, in which case it is designated necrotizing stomatitis (117). Periodontal disease in HIV-positive patients, like in non-seropositive patients, seems to be the result of the interaction between the host’s immune response and the microorganisms in dental plaque. There is increased rate of progression of periodontal disease in HIV patients, which seems to be modified by the interaction between typical and atypical microorganisms and the level of immunocompetence (98). In treating acute necrotizing ulcerative gingivitis in both normal and HIV patients, the fundamental activity must be the debridement of teeth and affected soft tissue areas. In classical cases of acute necrotizing ulcerative gingivitis the use of antibiotics without debridement has only served to suppress the infection while the medication is being taken. Actinomycosis Actinomycosis is a chronic disease characterized by the formation of abscesses, fibrosis of tissues and 114 draining sinuses. It is caused by non-spore-forming, anaerobic or microaerophilic bacterial species of the genus Actinoinyces. These organisms were once considered fungi because of their branching, but are now classified as bacteria (165). The pathogenic actinomycetes do not exist free in nature but are commensals and normal inhabitants of the oropharyngeal cavity and the gastrointestinal tract. The Actinomyces are gram-positive, pleomorphic and diphtheroidal or, more commonly, filamentous. Actinomycosis may present in the cervicofacial, thoracic and abdominal areas of the body, as well as the central nervous system. Cervico-facial actinomycosis is the most common form of this disease, and oral manifestations are part of this form (99). Actinomyces organisms access the host tissues when there is an interruption of the mucosal barrier. In the oral cavity actinomycosis has been reported following tooth extraction and may be a complication of endodontic treatment (49, 79, 183). Actinomyces involving localized atypical gingivitis has been described, and cases involving most of the oral tissues including the tongue and palate have been reported (49, 50, 73, 151, 183). As the Actinomyces infection spreads into the tissues, a hard, slow growing, relatively nontender swelling may form. Lesions of the bone and soft tissues may also show multiple abscesses that drain to the surface by sinus tracts. The discharge from the tracts typically contains visible yellowish colonies of organisms called “sulfur granules”. In late stages, osteomyelitis with extensive bone destruction may take place. The disease may become chronic, with old lesions healing, but new sinuses and abscesses develop (99, 151, 165). Most human infections are caused by Actinomyces israelii, but other species, Actinomyces viscosus, Actinomyces odontolyticus and Actinomyces naeslundii, have been identified in occasional cases (15, 23, 50, 64, 152, 183). Diagnosis is made most accurately by isolation of Actinomyces species in cultures of clinical specimens. Indirect immunofluorescence microscopy has also been utilized (64). The demonstration of actinomycotic granules in exudates or in histological sections is strongly supportive of the diagnosis. The granules consist of tangled filaments of organisms, which are apparent on microscopic examination of a Gram-stained smear. Histological diagnosis is difficult because many specimens contain only a few granules (165). Nagler et al. (119) recently discussed the diagnostic challenge associated with actinomycosis infections. In addition to the wide variety of clinical presentations, the Oral mucosal lesions caused by infectiue microorganisms. I. Viruses and bacteria authors also noted the difficulty associated with obtaining positive cultures. Actinomycosis was included in a list of bacterial diseases with oral manifestations, which have been reported to be associated with HIV (194) infection. In 1989, Pindborg noted a single case of actinomycosis in an HIV-positive patient (132). Since then, other cases have been reported, and although rare, actinomycosis should be carefully considered when diagnosing infections involving the cervicofacial areas in patients with AIDS (107, 183). Bacillary angiomatosis Bacillary angiomatosis, also called epithelioid angiomatosis, is a rare vasoproliferative disorder that occurs almost exclusively in severely immunocompromised persons, primarily AIDS and cancer patients and organ transplant recipients (6, 13, 32, 33, 61, 144, 146, 166, 172). It is known to cause both cutaneous and disseminated visceral disease in these patients. It has, however, also been reported, in immunocompetent individuals (128). It was first described by Stoler et al. in 1983 (171) as an unusual subcutaneous vascular infection in a patient with AIDS. The most common clinical presentation is a cutaneous vascular lesion similar to that of Kaposi’s sarcoma. There have been a limited number of reports of bacillary angiomatosis involving the oral cavity. The lesions have been described as bluish or purple macules, pale bluish patches, and red, edematous lesions occurring on the palate, buccal mucosa and attached gingiva (6, 33, 61, 166, 172). Only one report describes alveolar bone loss associated with the lesions, and in this patient, two teeth were extracted without complication (61). The challenge to the accurate diagnosis of bacillary angiomatosis lies in its clinical similarity to Kaposi’s sarcoma. Bacillary angiomatosis is treatable, and in most cases curable with antibiotic therapy. Biopsy confirmation of cases of suspected Kaposi’s sarcoma, particularly in patients with AIDS, is considered essential (32).The histological appearance of bacillary angiomatosis is one of lobular proliferation of small round blood vessels with plump endothelial cells that protrude into the vascular lumen. The aggregates of bacteria appear as variably sized, amphophilic granular masses, within the vessels, when stained with the Warthin-Starry stains (32). The causative organisms have been identified as Rochalimaea quintana and Rochalimaea henselae (6, 7, 13, 144, 164, 187) and have recently been reclassified as members of the genus Bartonella based on ribosomal RNA. Gonorrhea Gonorrhea is a sexually transmitted infection with a worldwide distribution. It is caused by Neisseria gonorrhoeae, a nonmotile, spherical or oval coccus, which is usually found in pairs. The organism is aerobic, gram-negative and stains readily. It cannot cross intact stratified squamous epithelium, such as skin and oral mucous membranes, but can invade columnar and transitional epithelium, such as that which lines the urinary and respiratory tracts. The urethra, pharynx, endocervix and conjunctivae may be infected directly. From these sites, the infection may spread locally along mucosal surfaces or systemically to produce disseminated disease (72, 159, 163). N. gonorrhoeae has been cultured from saliva of patients with oropharyngeal infections (81). The human is the only known host for N. gonorrhoeae (115). Gonorrhea continues to be the most frequently reported sexually transmitted disease in the United States. However, the 392,848 cases reported in 1995 do represent a decline from 439,673 cases reported in 1993 and reflect a steady reduction that has continued over the last decade (29). The most frequently affected population is adolescents between the ages of 15 and 24, although almost any age group can be afflicted (28). The most common cause of oral infections is orogenital contact with an infected sexual partner. Twenty percent of patients with gonorrhea have oral, pharyngeal or tonsillar involvement (186). The tonsils become red and swollen, with a grayish exudate, and may include cervical lymphadenitis. Lesions of the oral mucosa may present as a fiery red, edematous and occasionally painful ulceration. Case reports have described single or multiple ulcers of the tongue, gingiva, and buccal mucosa as well as the hard and soft palate (161). Diagnosis is made by culture and identification of N. gonorrhoeae. Sugar fermentation tests aid in species differentiation, and rapid identification of gonococci by fluorescent antibody techniques is possible (115). Systemic antibiotic treatment, usually with penicillin, has been effective in managing gonococcal infections. Beta-lactamase-producing strains of N. gonorrhoeae resistant to penicillin and tetracycline have been reported. More recently, ceftriaxone and ciprofloxacin have also been used successfully in treating gonorrhea (163). 115 Mycobacterial infections The term tuberculosis is usually reserved for infection with Rlycohacteriurn tuberculosis, just as leprosy is an infection with Mycobacterium Zeprae. Nontuberculous atypical mycobacterial diseases are generally identified as mycobacterial diseases with a specific organism - Mycobacteriurn kansasii, Mycobacteriiim chelonei and the Mycobacterium aviumirz tracellu lure complex ( 184). Most medical mycobacterial infections are not from M. tuberculosis but from nontuberculous opportunistic atypical mycobacteria. Cervical lymphadenitis caused by these bacteria can be successfully treated by surgical excision. These infections are not communicable from person to person and usually do not require systemic medication for months, as is the case with tuberculosis. Mycobacterial infections are among the most common opportunistic infections in I-IIV patients. Tuberculosis - M. tuberculosis. Tuberculosis is a chronic, infectious disease caused by the bacteria M. tuberculosis. It most commonly affects the lungs but may also involve any organ of the body. The disease is an airborne infection spread almost exclusively by droplets from a person with active disease (114, 131, 184). It is characterized by the formation of granulomas with caseation necrosis caused by a cell-mediated response in infected tissue. Tuberculosis, an ancient disease, reached its peak incidence in the United States in the nineteenth century, at that time being responsible for up to 25% of all deaths. Since then, there has been a dramatic decline, mainly as a result of improvements in living conditions, nutrition and chemotherapy (114). Recently, however, tuberculosis has resurfaced as a public health threat, in part because of its association with HIV infection. There is particular concern regarding increasing reports of multi-drug-resistant tuberculosis in patients with AIDS. This resurgence has renewed interest in tuberculosis among health care providers, especially those who treat hospitalized patients with AIDS (110, 114, 131, 184). Primary tuberculosis involves a person who has no previous exposure and has never established an iniiiiune response to the tubercle bacilli. The majority of cases are subclinical, and only about 10% of people infected develop the disease (131). Secondary tuberculosis is an infection that arises in a previously sensitized person, usually because of reactivation of a primary infection, and may occur months to years later. Oral lesions of tuberculosis are rare, occurring 116 in less than 1% of all pulmonary cases (110). Most reported cases have been attributed to secondary infection from pulmonary lesions. Self-inoculation from infected sputum and hematogenous spread account for initiation of the lesions. The most common oral tuberculosis lesion is a chronic, painless, irregular ulcer, with a vegetating surface covered by a gray or yellowish exudate. Other reports describe a nodular, granular or leukoplakic appearance. The lesion is usually surrounded by edematous and hyperemic mucosa. The dorsal surface of the tongue is the most common oral site, followed by the palate, gingiva, buccal mucosa, and lips. Tuberculosis of the cervical lymph nodes is called scrofula and may result in breakdown of the skin overlying the nodes and fistula formation (41, 44, 45, 83, 127, 131, 139). Primary oral mucosal infection with the tubercle bacillus has been reported in patients treated by a dentist with active tuberculosis after the dentist performed dental extractions. This occurred prior to the use of barrier protection for infection control (149). Other case reports described primary tuberculosis and oral lesions in patients with no evidence of disseminated disease (41,56,83,95,185). Diagnosis of infection with M. tuberculosis is derived from the medical history, demonstration of the acid-fast mycobacteria in clinical specimens, a positive delayed hypersensitivity (tuberculin) skin reaction to purified protein derivative and chest radiographs. Mycobacterial culture of the organism from sputum is the most reliable means of diagnosis; however, 6-12 weeks is required to isolate and identify the organism. Recent developments in rapid detection and identification are reducing laboratory time (44, 114, 131). Leprosy - M. leprae. Leprosy is a chronic disease caused by M. Zeprae. The most characteristic feature of the disease is damage to nerves and skin, which results in deformities and disabilities. While the global prevalence has been reduced, leprosy remains a major public health problem in most countries of Africa, Asia and Latin America (85). M. Zeprae is a gram-positive, acid-fast, non-sporeforming, nonmotile, pleomorphic bacillus. It has not been cultivated on artificial medium or in tissue cultures, but it has been grown in armadillos and the footpads of some mice (85, 155). A relationship has been demonstrated between the clinical, histopathological and bacteriological manifestations of the disease and the degree of cell-mediated immunity of the patient. The Mitsuda reaction is used to assess cellular immunity, with a positive test reflecting re- Oral rnucosal Lesions caused bv infectiue microornanisms. 1. Viruses and bacteria sistance to the organism. There are four types of leprosy listed, from least to most involved: indeterminate, tuberculoid, borderline and lepromatous. In addition to skin and peripheral nerves, the disease also affects oral and respiratory mucosa, bones and viscera (85). Oral lesions have been reported in the tuberculoid, borderline, and lepromatous types of leprosy. The incidence varies from less than 20% in the borderline type, to as high as 60% in patients with lepromatous leprosy (4, 24, 77, 155). The lesions present as nodules (lepromas) that progress to necrosis and ulceration. The ulcers may then heal with scarring, or progress on to cause further tissue destruction. The lepromas are filled with M. leprae. The oral lesions of leprosy occur on the palate, dorsum of the tongue, gingiva, uvula and the lips, and when untreated, may cause extensive destruction of the oral tissues (4, 24, 77, 142, 155). Diagnosis is based on the clinical signs of anesthetic skin lesions, enlarged peripheral nerves and the presence of acid-fast bacilli in smears taken from skin lesions. Histological examination of biopsy specimens is occasionally necessary. At this time, there is no immunological test that is useful in the diagnosis of leprosy (85). Mycobacterium avium-intracellulare complex infection. Opportunistic infection by the M. avium-intracellulare complex is a common complication of the latter stages of AIDS (16, 175). Oral lesions of the M. avium-intracellulare complex are uncommon and have been reported only in two patients. The lesions presented as ulcerations with firm borders and necrotic centers which extended to bone. They were located in the incisive papilla and edentulous maxillary ridge areas of one patient, and in the buccal gingiva of the maxillary premolars and molars of the other patient. Diagnosis in both cases was made from histopathological examinations and culture of the organisms from tissue biopsy. Both patients also demonstrated widespread disseminated infection with the M. avium-intracellulare complex (148, 181). Mycobacterium bovis infection. On rare occasions, human tuberculosis has been caused by M. bovis, and infections of the tongue and gingiva have been reported. The pathogenesis is similar to M. tuberculosis except that the primary inoculation occurs in the mouth, probably the result of ingesting unpasteurized or infected milk. Primary lesions of the tongue without evidence of tuberculosis elsewhere in the body have been described (41). Mycobacterium chelonae infection. M. chelonae is an opportunistic pathogen that causes abscess formation, usually in skin, following trauma or subcutaneous injections. The organism is rapidly growing and resistant to standard antituberculosis agents as well as to antibiotics. Lesions in immunocompetent patients heal spontaneously, however surgical excision, debridement and drainage are recommended to enhance healing. There have been two case reports of intraoral infections attributed to M. chelonae. Both cases were diagnosed after biopsy and laboratory evaluations and healed slowly, but without incident (21, 129). Cervicofacial infection with M. chelonae has also been reported with similar findings (19). Mycobacterium kansasii infection. Several cases of disseminated M. kansasii infection have been reported in patients with AIDS (10, 25, 122). Only one patient, however, has demonstrated oral manifestations associated with the M. kansasii infection. This consisted of an ulcerated lesion in the area of the palatoglottic arch in a patient with disseminated disease. M. kansasii was cultured from the ulcer biopsy. The patient did not demonstrate signs or symptoms of pneumonia, and the disseminated infection was diagnosed from bone marrow and blood specimens (122). Streptococcal stomatitis Streptococcal stomatitis is a rare condition, usually characterized by a diffuse erythema of the posterior areas of the oral mucosa, but sometimes includes the gingiva. Acute gingival streptococcal infections have been described as acute streptococcal gingivostomatitis, acute streptococcal gingivitis and streptococcal gingivostomatitis, with only a few case reports in the literature (20, 26, 104, 121). It is, however, described in several periodontal textbooks (26, 121, 133, 134). Acute streptococcal gingivostomatitis is usually preceded by tonsillitis, and the patients present clinically with an acutely inflamed, diffuse, red and swollen gingiva with an increased tendency to bleed. The gingiva is not ulcerated and necrosis is not present (20, 104, 177).Gingival abscesses in the interdental papillae and areas with discrete yellowish or white plaques were described in a few patients. When the plaques were wiped off, a bleeding surface was produced (20, 177). In some patients, the erythema also involved areas of oral mucosa with submandibular lymph node enlargement. Fever, mal- 117 I? i vem - Hidalgo & Stanford aise, and gingival pain accompany these symptoms (20, 104, 177). ‘The causative agent of streptococcal stomatitis was originally thought to be Streptococcus viriduns, but microbial analysis in recent reports found group A beta-hemolytic streptococci as the predominant culture organisms. All patients were treated with systemic penicillin and healed without complications. A few patients also received a tetracycline mouthrinse concurrently (104). ‘The symptoms attributed to streptococcal gingivostomatitis - diffusely swollen, bright red gingiva, fever, malaise, and lymph node enlargement - may also be associated with viral infections, and careful diagnosis is necessary. Syphilis Syphilis is a venereal disease that has infected humans for centuries. It is caused by the spirochete li.qionernn pallidurn. Syphilis is the fourth most comrnonly reported infectious disease in the United States. In 1995, the total number of reported cases of primary and secondary syphilis was 16,500. This represented a decrease from the 26,498 reported in 1993 and continues a downward trend in the number of annually reported cases since the epidemic proportions during the years 1986 through 1990 (29, 163). Syphilis has been classified as either congenital or acquired. Congenital syphilis occurs most frequently when the fetus becomes infected in utero, although it is possible for the neonate to acquire the infection as it passes through the birth canal (176). Acquired syphilis may be contracted by sexual contact, by transfusion with fresh human blood or by accidental direct inoculation. The acquisition of syphilis through transfusion has become rare due to screening procedures for blood donors and modern blood bank procedures. Accidental direct inoculation has also been reduced by improved laboratory proceduies for handling infected clinical material and by the use of infection control and barrier procedures in clinical settings. There have been no reports of occupationally acquired syphilis in a dental office since the advent of improved infection control procedures. The overwhelming majority of syphilis cases, however, continue to be transmitted by sexual intercourse (161, 163, 176). Early congenital syphilis may manifest as papulosquanious lesions ot the skin and oral mucous membranes. ‘The lesions at the conimissures of the lips, the angle of the nose and the eyes may heal with 118 radiating scars called rhagades. Oral manifestation of late congenital syphilis includes Hutchinson’s triad of deafness, interstitial keratitis and malformed incisors. In addition to the malformed incisors (Hutchinson’s teeth), other dental anomalies include permanent molars with hypoplastic, poorly developed cusps called mulberry molars, and maxillary incisors with crowns that are wider towards the cementoenamel junction than at the incisal edge, producing a screwdriver appearance. Acquired syphilis occurs clinically in three classical phases (primary, secondary and tertiary). Primary syphilis features formation of a chancre at the site of inoculation, usually 3 weeks (3 to 90 days) after contact. The chancre appears on skin or in the oral cavity as an asymptomatic, centrally ulcerated granulomatous papule with a raised indurated border. Spirochetes are present in large numbers in these highly infectious lesions. Chancres usually heal spontaneously in 2-8 weeks but may persist in immunocompromised hosts (161, 163, 176). Secondary syphilis is the systemic or disseminated phase, and it may occur 2-12 weeks (mean, 6 weeks) after contact. The healing chancre may still be present. Signs and symptoms of this phase include fever, headache, malaise, a rash that is usually symmetrical and generalized painless lymph node involvement. The oral lesion of this stage is the mucous patch, a characteristic grayish-white, glistening patch seen on the soft palate, tongue, buccal mucosa and, rarely, the gingiva (11, 51, 88, 108, 140). During this phase, elevated, sessile plaques of the labial commissure (condyloma lata) may also occur. After the secondary stage subsides, the patient enters a latent period in which diagnosis can only be made by serological tests. Tertiary syphilis develops in 30% to 40% of untreated patients. This phase includes multiorgan involvement, and most frequently involves the cardiovascular and nervous systems. The gumma is the characteristic lesion of this phase and appears on skin or mucosa as a localized granuloma. The most common intraoral location for the gumma is the hard palate, although the soft palate, lips and tongue may also be involved (40, 84, 92). Tertiary syphilis is not infectious (163). Clinical examination and serological testing usually diagnose syphilis. Darkfield microscopy and histopathological examination also assist in diagnosis. The serological tests are of two types: treponema1 and non-treponemal. Non-treponemal (nonspecific) tests are for the nonspecific nontreponemal reaginic antibody, and include the Venereal Disease Research Laboratory test, the rapid plasma reagin Oral mucosal lesions caused bv infective microorganisms. I. Viruses and bacteria test and the automated reagin test. Positive Venereal Disease Research Laboratory tests will occur towards the end of primary syphilis, remain positive in untreated secondary or tertiary syphilis, but is usually negative in treated syphilis. Treponemal (specific) tests are for the specific antitreponemal antibody, and include the Reiter protein complement fixation test, the fluorescent treponemal antibody (absorbed) test, the treponemal hemagglutination test and the treponemal immobilization test. Specific tests become positive during primary syphilis, and remain positive throughout untreated secondary and tertiary syphilis. In contrast to the Venereal Disease Research Laboratory test, most specific tests remain positive in treated syphilis (161). Darkfield microscopy can be useful in primary syphilis when serology may be negative, and occasionally in secondary or tertiary syphilis. Histopathological examination demonstrates an obliterative endarteritis, and with special stains, the I: pallidurn microorganism. The gumma demonstrate large areas of necrosis and occasional microorganisms (161, 163, 176). Penicillin is the pharmaceutical treatment of choice. Treatment given in any of the three stages of acquired syphilis can cure the disease (176). Concomitant HW and syphilis infections are common, and variations in the clinical presentation and response to syphilis may be related to the degree of immunosuppression (40, 51, 176). Oral infection with enteric organisms A small number of cases of oral infections with enteric bacteria have been reported (12, 68, 158, 167). Schmidt-Westhausen et al. (158) using oral swabs, compared the incidence of enteric bacteria in the oral cavity of 144 HIV patients and 166 controls. They found enteric bacteria in 5.0% of HW patients and 4.8% of the controls. The isolation of the enteric organisms from the oral cavity was not associated with clinical abnormalities. The bacteria were found to coexist with yeast (68). Barone et al. (12) reported on an HIV-seropositive patient with glossitis from whom Escherichia coli could be isolated. In another report, Stark et al. (167) reported that, of 14 patients treated with a combination of antibiotics for Helicobacter pylori infection, two patients had colonization of the oral cavity with Enterobacteriaceae.Heitman & Brasher (75) reported an oral infection due to Klebsiella pneumoniae, an organism indigenous to the respiratory tract, in a patient following periodontal surgery. Culture and antibiotic sensitivity testing, followed by treatment with tetracycline resolved this infection (75). It seems unlikely that oral infection with enteric organisms is a significant cause of morbidity in people infected with HW. References 1. Ablashi DV, Salahuddin SZ, Josephs SE Balachandran N, Krueger GR, Gallo RC. Human herpesvirus-6 (HHV-6).In Vivo 1991:5: 193-199. 2. Adolph HP, Yugueros P, Woods JE. Noma: a review. Ann Plast Surg 1996:37: 657-668. 3. AIDS among persons aged 250 years - United States, 1991-1996. MMWR Morb Mortal Wkly Rep 1998: 47: 2127. 4. Alferi N, Fleury RN, Opromolla DVA, Ura S, de Campos I. Oral lesions in borderline and reactional tuberculoid leprosy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1982:55:52-57. 5. Atedzoe BN, Ahamad A, Menezes J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus7 via IL-15induction. J Immunol 1997: 159: 49664972. 6. Axiotis CA, Schwartz R, Jennings TA, Glaser N. AIDS-related angiomatosis. Am J Dermatopathol 1988: 11: 177181. 7. Bachelez H, Oksenhendler E, Lebbe C. Bacillary angiomatosis in HIV-infected patients: report of three cases with different clinical courses and identification of Rochalimaea quintana as the etiological agent. Br J Dermatol 1995: 133: 983-989. 8. Bagg J. Common infectious diseases. Dent Clin North Am 1996:40: 385-393. 9. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995:61:450454. 10. Bamberger DM, Dirks MR, Gupta MR, O’Connor MC, Jost PM, Neihart RE, McKinsey DS, Moore LA. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis 1994: 18: 395-400. 11. Ban M, Ohtani M, Seishima M. A case of secondary syphilis with mucous patches o n the hard palate. J Dermatol 1995:22: 52-54. 12. Barone R, Ficarra D, Gaglioti A, Orsi A, Mazzotta F. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1966:69: 169-173. Vincent JM, Pearson DA. The expanding spec13. Bass JW, trum of Bartonella infections. 11. Cat-scratch disease. Pediatr Infect Dis J 1997: 16:163-179. Fleming DM. Epidemiological, virological, and 14. Bendig JW, clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun Dis Rep CDR Rev 1996:6:R81-86. 15. Bennhoff F. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope 1984:94: 1198-1217. 16. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis 1993: 17: 7-20. 119 Rivera-Hidalgo & Stanford 17. Bertram G, Dreiner N, Krueger GR, Ramon A, Ablashi DV, Salahuddin SZ, Balachandram N. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis. In Vivo 1991: 5: 271-279. 18. Black JB, Durigon E, Kite-Powell K, de Souza L, Curli SE Alfonso AM, Theobaldo M, Pellett PE. Seroconversion to human herpesvirus 6 and human herpesvirus 7 among Brazilian children with clinical diagnosis of measles or rubella. Clin Infect Dis 1996: 23: 1156-1158. 19. Blake CG, Murray JJ, Lee Kw. Cervico-facial infection with Mycobacteriurn ckelonei - a case report. Br J Oral Surg 1976: 13: 278-281. 20. Blake GC, Trott JR. Acute streptococcal gingivitis. Dent Pract Dent Rec 1959: 10: 43-45. 21. Boyd BW. Oral infection with associated lymphadenopathy due to Mycobacteriurn ckelonei. Ala Med 1984: 54: 9-10, 22. Brooks LA, Wilson AJ, Crook T. Kaposi’s sarcoma-associated herpesvirus (KSVH)/human herpesvirus 8 (HHV8) a new human tumour virus. J Pathol 1997: 182: 262-265. 23. Brown J. Human actinomycosis: a study of 181 patients. Hum Pathol 1973: 4: 319-330. 24. Bucci F, Mesa M, Schwartz RA, McNeil G, Lambert WC. Oral lesions in lepromatous leprosy. J Oral Med 1987: 42: 4-6. 25. Carpenter JL, Parks JM. Mycobacteriurn kansasii infection in patients positive for human immunodeficiency virus. Rev Infect Dis 1991: 13: 789-796. 26. Carranza FA. Acute gingival infections. In: Carranza FA, Newman MG, ed. Clinical periodontology. 8th edn. Philadelphia: Saunders, 1996: 249-258. 27. Castanet J, Rodot S, Lacour JE Van Elslande L, Perrin C, Durant J, Ortonne JR Chronic varicella presenting as disseminated pinpoint-sized papule in a man infected with the human immunodeficiency virus. Dermatology 1996: 192: 84-86. 28. Centers for Disease Control. Special focus: surveillance for sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1993: 42(SS-3): 1-39. 29. Centers for Disease Control. Summary notifiable diseases, United States, 1995. MMWR Morb Mortal Wkly Rep 1996 44: 7-33. 30. Chang Y, Moore PS. Kaposi’s sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 1996: 5: 215-222. 31. Chidzonga MM. Noma (cancrum oris) in human immunodeficiency virus/acquired immune deficiency syndrome patients: report of eight cases. J Oral Maxillofac Surg 1996: 5 4 1056-1060. 32. Cockerell CJ, LeBoit PE. Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder. J Am Acad Dermatol 1990: 22: 501-512. 33. Cockerell CJ, Whitlow MA, Webster GF, Freidman-Kien AE. Epitheloid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrime or AIDS-related complex. Lancet 1987: 2: 654-656. 34. Cohen PR, Hebert AA, Adler-Storthz K. Focal epithelial hyperplasia: Heck disease. Pediatr Dermatol 1993: 10: 245251. 35. Contreras A, Slots J. Mammalian viruses in human periodontitis. Oral Microbial Immunol 1996: l l: 381-386. 36. Cutts FT, Clements CJ, Bennet JV Alternative routes of 120 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. measles immunization: a review. Biologicals 1997: 25: 323-338. Daniels TE, Greenspan D, Greenspan JS, Lennette E, Schiodt M, Petersen V, de Souza Y. Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion. J Invest Dermatol 1987: 89: 178-182. Dean JA, Magee W. One-stage reconstruction for defects caused by cancrum oris (noma). Ann Plast Surg 1997: 38: 29-35. Dhariwal SK, Cubie HA, Southam JC. Detection of human papillomavirus in oral lesions using commercially developed typing kits. Oral Microbiol Immunol 1995: 10: 6063. Dickenson AJ, Currie WJR,Avery BS. Screening for syphilis in patients with carcinoma of the tongue. Br J Oral Maxillofac Surg 1995: 33: 319-320. Dimitrakopoulos 1, Zouloumis L, Lazaridis N, Karakasis D, Trigonidis G, Sichletidis L. Primary tuberculosis of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1991: 72: 712-715. Drago F, Ranieri E, Malagiti F, Losi E, Rebora A. Human herpesvirus 7 in pityriasis rosea. Lancet 1997: 349: 13671368. EC Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Human Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HW infection. J Oral Pathol Med 1993: 22: 289-291. Ellner PD, Kiehn TE, Cammarata R, Hosmer M. Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods. J Clin Microbiol 1988: 26: 1349-1352. Eng HL, Lu SY, Yang CH, Chen WJ. Oral tuberculosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 415-420. Epstein JB. Treatment of Kaposi’s sarcoma with intralesional vinblastine. Cancer 1993: 71: 1722-1725. Eversole LR. Inflammatory diseases of the mucous membranes. 1. Viral and fungal infections. J Calif Dent Assoc 19984: 22: 52-57. Eversole LR. Cause of ulcers in HIV-infected patients: a study of 19 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 82: 166-172. Feder HM. Actinomycosis manifesting as an acute painless lump of the jaw. Pediatrics 1990: 85: 858-863. Ficarra G, DiLollo S, Pierieoni E Panzoni E. Actinomycosis of the tongue: a diagnostic challenge. Head Neck 1993: 15: 53-55. Ficarra G, Zaragoza AM, Stendardi L, Parri E Cockerell. Early oral presentation of lues inaligna in a patient with HIV infection. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1993: 75: 728-732. Flaitz CM, Nichols CM, Adler-Storthz K, Hicks MJ. Intraoral squamous cell carcinoma in human immunodeficiency virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995: 80: 55-62. Flaitz CM, Nichols CM, Hicks MJ. Herpesviridue-associated persistent mucocutaneous ulcers in acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 433-441. Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang W, Su IJ. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences (KSHVIHHV-8) in oral AIDS-Kaposi’s sarcoma: a Oral mucosal lesions caused by infective microorganisms. I. Viruses and bacteria 55. 56. 57. 58. PCR and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 83: 259-264. Flores JL. Syphilis. A tale of twisted treponemes. West J Med 1995: 163: 552-559. Fujimoto T, Morishima T, Ueda M. Probable BCG osteomyelitis of the hard palate: a case report. Int J Oral Maxillofac Surg 1996: 25: 145-146. Ganem D. KSHV and Kaposi’s sarcoma: the end of the beginning? Cell 1997: 91: 157-160. Garlick JA, Taichman LB. Human papillomavirus infection of the oral mucosa. Am J Dermatopathol 1991: 13: 386- 395. 59. Gaspari AA, Marchese S, Powell D, Rady PL, w i n g SK. Identification of HHV-8 in the skin lesions of Kaposi’s sarcoma in an immunosuppressed patient with bullous pemphigoid. J Am Acad Dermatol 1997: 3 7 843-847. 60. Ginsburg CM. Pityriasis rosea. Pediatr Infect Dis J 1991: 74. Hashmey R, Shandera WX. Infectious diseases: viral and rickettsial. In: Tierney LM Jr, McPhee SJ, Papadakis MA, ed. Current medical diagnosis and treatment. 36th edn. Stamford, CT: Appleton and Lange, 1997: 1203-1237. 75. Heitman KL, Brasher WJ. Oral infection due to Klebsiella pneumonia microorganism: case report. J Periodontol 1971: 42: 552-554. 76. Helfand RE Kebede S, Alexander JP Jr, Alemu W, Heath JL, 77. 78. 79. 10: 858-859. 61. Glick M, Cleveland DB. Oral mucosal bacillary epitheloid 80. angiomatosis in a patient with AIDS associated with rapid alveolar bone loss: case report. J Oral Med 1993: 22: 235239. 62. Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing ul- cerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 1994: 65: 393-397. 63. Goedert JJ, Kedes DH, Ganem D. Antibodies to human herpesvirus 8 in women and infants in Haiti and the USA. Lancet 1997: 349: 1368. 64. Gohean RJ, Pantera EA, Schuster SG. Indirect immunoflu- orescence microscopy for the identification of Actinomyces sp. In endodontic disease. J Endod 1990: 16: 318-322. 65. Gominak S, Cross D, Paydafar D. Herpes simplex labialis and trigeminal neuropathy. Neurology 1990: 40: 151-152. 66. Green TL, Greenspan D, Greenspan JS, de Souza YG. Oral lesions mimicking hairy leukoplakia: a diagnostic dilema. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 67: 422-426. 81. Gary HE Jr, Anderson LJ, Beyene H, Bellini WJ. Comparative detection of measles-specific IgM in oral fluid and serum from children by a n antibody-capture IgM EM. J Infect Dis 1996: 173: 1470-1474. High AS, Lansley CV. Labial and gingival enlargement in leprosy. Br Dent J 1988: 165: 371-372. Hirschfeld I, Beube F, Siege1 EH. The history of Vincent’s infection. J Periodontol 1940: 11: 89. Holbrook W. Bacterial infections of oral soft tissues. Curr Opin Dent 1991: 1: 404410. Horning GM, Cohen ME. Necrotizing ulcerative gingivitis, periodontitis, and stomatitis: clinical staging and predisposing factors. J Periodontol 1995: 66: 990-998. Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med 1986: 104: 655- 658. 82. Itin PH. Oral hairy leukoplakia - 10 years on. Dermatology 1993: 187: 159-163. 83. Jawas J, El-Zuebi E Primary lingual tuberculosis: a case report. J Laryngol Otol 1996: 110: 177-178. 84. Jefferies SBD, Ord RA. An unusual presentation of oral syphilis. Br Dent J 1985: 23: 376-380. 85. Ji B, Grosset J. Leprosy. In: Hoeprich PD, Jordan MC, Ron- ald AR, ed. Infectious diseases. 5th edn. Philadelphia: Lippincott, 1994. 86. Jones AC, Freedman PD, Phelam JA, Baughman RA, Kerpel SM. Cytomegalovirus infections of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1993: 75: 76-85. 87. Jontell M, Watts S, Wallstrom M, Levin L, Sloberg K. Hu- 67. Greenberg MS. Herpesvirus infections. Dent Clin North Am 1996: 40: 359-368. 68. Greenspan D, Greenspan J, Pinborg J, Schiodt M. AIDS and the mouth. Copenhagen: Munksgaard, 1990. 69. Greenspan D, Greenspan JS, Conant M, Petersen V, Sil- man papilloma virus in erosive lichen planus. J Oral Pathol 1990: 19: 273-277. 88. Jordaan HE Secondary syphilis: a clinicopathological study. Am J Dermatopathol 1988: 10: 399409. 89. Juel-Jensen BE. Herpes simplex and zoster. BMJ 1973: 1: verman S Jr, De Souza Y. Oral “hairy” leukoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984: 13: 831- 406-410. 90. Juel-JensenBE. Herpetic whitlowes: an occupational risk. Anesthesia 1973: 28: 324-327. 91. Karlin JD. Herpes zoster ophthalmicus: the virus strikes back. Ann Opthalmol 1993: 25: 208-215. 92. Kearns G, Pogrel MA, Honda G. Intraoral tertiary syphilis 834. 70. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK. Replication of EpsteinBarr virus within epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N Engl J Med 1985: 313: 1564-1571. 71. Greenspan D, Greenspan JS, Hearst NG, Pan LZ,Conant MA, Abrams DI, Hollander H, Levy JA. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987: 155: 475481. 72. Guinta JL, Fiumara NJ. Facts about gonorrhea and dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1986: 62: 529-531. 73. Gulabivala K, Briggs PFA. Diagnostic dilemma: an unusual presentation of an infected nasopalatine duct cyst. Int Endod 1992: 25: 107-1 11. (gumma) in a human immunodeficiency virus-positive man: a case report. J Oral Maxillofac Surg 1993: 51: 8588. 93. KemCny L, Gyulai R, Kiss M, Nagy F, Dobozy A. Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology. J Am Acad Dermatoll997: 37: 107-113. 94. Kimberlin DW. Human herpesvirus 6 and 7: identifi- cation of newly recognized viral pathogens and their association with human disease. Pediatr Infect Dis J 1998: 17 59-68. 95. Kolokotronis A, Antonidis D, Trigonidis G, Papanagiotou F! Oral tuberculosis. Oral Dis 1996: 2: 242-243. 96. Kriesel JD, Pisani PL, McKeough MB, Baringer JR, Spru- 121 Rivera-Hidalzo & Stanford ance SL. Correlation between detection of herpes simplex virus in oral secretions by PCR and susceptibility to experimental UV radiation-induced herpes labialis. J Clin Microbiol 1994: 32: 3088-3090. 97. Kushner D, Caldwell BD. Hand-foot-and-mouth disease. J Am Podiatr Med Assoc 1996: 86: 257-259. 98. Lamster IB, Grbic JT, Bucklan RS, Mitchell-Lewis D, Reynolds HS, Zambon JJ. Epidemiology and diagnosis of HIVassociated periodontal diseases. Oral Dis 1997: 3(suppl): S141-S148. 99. Laskaris G. Oral manifestations of infectious diseases, Dent Clin North Am 1996: 40: 395-423. 100. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet 1996: 348: 858-881. 101. Levy JA, Ungar AM. Oral hairy leukoplakia in an HIVnegative renal transplant recipient. J Oral Pathol Med 1989: 18: 32-34. 102. Levy JA. Three new human herpesviruses (HHV6, 7, and 8). Lancet 1997: 349: 558-583. 103. Listgarten MA. Electron microscopy observations on the bacterial flora of acute necrotizing ulcerative gingivitis. J Periodontol 1965: 36: 328. 104. Littner MM, Dayan D, Kaffe I, Begleiter A, Gorsky M, Moskana D, Buchner A. Acute streptococcal gingivostomatitis. Report of five cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1982: 53: 144-147. 105. Luppi M, Torelli G. Hematologica 1996: 81: 265-281 106. Lusso P, De Maria A, Malnati M, Lori E DeRocco SE, Baseler M, Gallo RC. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature 1991: 349: 533-535. 107. Manfredi R, Mazzoni A, Marinacci G, Nanetti A, Chiodo F. Prograssive intractable actinomycosis in patients with AIDS. Scand J Infect Dis 1995: 27: 405-407. 108. Manton SL, Egglestone SI, Alexander I, Scully C. Oral presentation of secondary syphilis. Br Dent J 1986: 160: 237-238. 109. Mao EJ, Schwartz SM, Daling JR, Oda D, Tickman L, Beckmann AM. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer 1996: 69: 152-158. 110. Mattingly G, Rodu B. Differential diagnosis of oral mucosal ulcerations. Compendium Contin Educ Dent 1993: 14: 136-150. 111. McCreary CE, Flint SR, McCartan BE, Shields JA, Mabruk M, Toner ME. Uremic stomatitis mimicking oral hairy leukoplakia: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 83: 350-353. 112. Mealy BL. Periodontal implications: medically compromised patients. Ann Periodontol 1996: 1: 256-322. 113. Miller CS. Viral infections in the immunocompetent patient. Dermatol Clin 1996: 14: 225-241. 114. Molinari JA, Cottone JA, Chandrasekar PH. Tuberculosis in the 1990s: current implications for dentistry. Compendium Contin Educ Dent 1993: 14: 276-292. 115. Morse SA, Holmes KK. Infectious diseases. 5th edn. Philadelphia: Lippincott, 1994. 116. Murayama Y, Kurihara H, Nagai A, Dompkowski D, Van Dyke TE. Acute necrotizing ulcerative gingivitis: risk factors involving host defense mechanisms. Periodontol 2000 1994: 6: 116-124. 117. Murray PA. Periodontal disease in patients infected by hu- 122 man immunodeficiency virus. Periodontol 2000 1994: 6: 50-67. 118. Muto T, Tsuchiya H, Sat0 K, Kanazawa M. Tooth exfoliation and necrosis of the mandible. A rare complication following trigeminal herpes zoster. J Oral Maxillofac Surg 1990: 48: 1000-1003. 119. Nagler R, Peled M, Laufer D. Cervicofacial actinomycosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 83: 652-656. 120. Nakagawa N, Mukai T, Sakamoto J, Hata A, Okunp T, Takeda K, Yamanishi K. Antigenic analysis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies against HHV-7. J Gen Virol 1997: 78(part 5): 1131-11377. 121. Newman HN. The classification of periodontal diseases. In: Newman HN, Rees TD, Kinane DF, ed. Diseases of the periodontiurn. Northwood: Science Reviews Limited, 1993: 8-26. 122. Nuesch R, Battegay M, Zimmerli W, Thumshirn M, Gilli L, Itin PH. OraI manifestation of disseminated Mycobucterium kansasii in a patient with AIDS. Dermatology 1996: 192: 183-184. 123. Oakley C, Epstein JB, Sherlock CH. Reactivation of oral herpes simplex virus recurrence during radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 84: 272-278. 124. Obalek S, Janniger C, Jablonska S, Favre M, Orth G. Sporadic cases of Heck disease in two polish girls: association with human papillomavirus type 13. Pediatr Dermatol 1993: 10: 240-244. 125. Padayachee A. Human papillomavirus (HPV) types 2 and 57 in oral verrucae demonstrated by in situ hybridization. J Oral Pathol Med 1994: 23: 413-417. 126. Palefsky JM, Silverman S Jr, Abdel-Salaam M, Daniels TE, Greenspan JS. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 1995: 24: 193-197. 127. Pande TK, Hiran S, Rao VVB, Pani S, Vishwanathan KA. Primary lingual tuberculosis caused by M. bovis infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995: 80: 172-174. 128. Paul MA, Fleischer AB, Wieselthier JS, White WL. Bacillary angiomatosis in an immunocompetent child: the first reported case. Pediatr Dermatol 1994: 11: 338-341. 129. Pedersen A, Reibel J. Intraoral infection with Mycobacterium chelonue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1989: 67: 262-265. 130. Perry CM, Wagstaff AJ. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections. Drugs 1995: 50: 396-415. 131. Phalen JA, Jimenez V, Tompkins DC. Tuberculosis. Dent Clin North Am 1996: 4 0 327-341. 132. Pindborg J. Classification of oral lesions associated with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1989: 67: 292-295. 133. Pindborg JJ. Manifestation of systemic disorders in the periodontium. In: Lindhe J, ed. Textbook of clinical periodontology. 2nd edn. Copenhagen: Munksgaard, 1989: 282-296. 134. Pindborg JJ. Atlas of diseases of the oral mucosa. 5th edn. Copenhagen: Munksgaard, 1993: 180. 135. Praetorious E HPV-associated diseases of oral mucosa. Clin Dermatol 1997: 15: 399413. Oral mucosal lesions caused by infective microorganisms. I. Viruses and bacteria 136. Premoli-de-Percoco G, Cisternas JP, Ramirez JL, Galindo I. Focal epithelial hyperplasia: human papillomavirus-induced disease with a genetic predisposition in a Venezuelan family. Hum Genet 1993: 91: 386-388. 137. Premoli-de-Percoco G, Galindo I, Ramirez JL, Perrone M, Rivera H. Detection of human papillomavirus-related oral verruca vulgaris among Venezuelans. J Oral Pathol Med 1993: 22: 113-116. 138. Puranen M, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 1996: 174: 694-699. 139. Purohit SD, Mathur BB, Gupta PR, Agarwal KC, Hathi HH. Tuberculous fistula of cheek report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1985: 60: 41-42. 140. Ramirez-Amador V, Sierra Madero JG, Esquivel Pedraza LE, de la Rosa Garcia E, Gonzalez Guevara M, Reyes Gutierrez E, Reyes-Teran G. Oral secondary syphilis in a patient with human immunodeficiency virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 652-654. 141. Regezi JA, Eversole LR, Baker BE Rick GM, Silverman S. Herpes simplex and cytomegalovirus coinfected oral ulcers in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 55-62. 142. Reichart P, Ananatasan T, Reznik G. Gingiva and periodontium in lepromatous leprosy. J Periodontol 1976: 47: 455460. 143. Reichart PA. Oral manifestations of recently described viral infections. Curr Opin Dent 1991: 1: 377-383. 144. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis. N Engl J Med 1990: 323: 1573-1580. 145. Rentier B, Piette J, Baudoux L, Debrus S, Defechereux P, Merville MP, Sadzot-Delvaux C, Schoonbroodt S. Lessons to be learned from varicella-zoster virus. Vet Microbiol 1996: 53: 55-66. 146. Rhame FS. Acquired immunodeficiency syndrome. In: Hoeprich PD, Jordan MC, Ronald AR, ed. Infectious diseases. 5th edn. Philadelphia: Lippincott, 1994: 628-632. 147. Robayna MG, Herranz P, Rubio FA, Pena P, Pena JM, Gonzalez J, Casado M. Destructive herpetic whitlow in AIDS: report of three cases. Br J Dermatol 1997: 37: 812-815. 148. Robinson E: Farthing E: Scott GM, Bennett JH. Oral Mycobacterium auiurn complex infection in a patient with HIVrelated disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 177-179. 149. Roderick Smith WHR, Davis D, Mason KD, Onions I€? Intraoral and pulmonary tuberculosis following dental manipulation. Lancet 1982: 1: 842-843. 150. Rosebury T. The role of infection in periodontal disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1952: 5: 363. 151. Rubin MM, Krost BS. Actinomycosis presenting as a midline palatal defect. J Oral Maxillofac Surg 1995: 53: 701703. 152. Sa’do B, Yoshiura K, Yuasa K, Ariji Y, Kanda S, Oka M, Katsuki T. Multimodality imaging of cervicofacial actinomycosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1993: 76: 772-782. 153. Sada E, Yasukawa M, Ito C, Takeda A, Shiosaka T, Tanioka H, Fujita S. Detection of human herpesvirus 6 and human herpesvirus 7 in the submandibular gland, parotid gland, and lip salivary gland by PCR. J Clin Microbiol 1996: 34: 2320-2321. 154. Salahuddin SZ, Ablashi D\5 Markharn PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, WongStaal F, Kramarsky B. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986: 234: 596-601. 155. Sawyer DR, Nwoku AL, Lehnert JF. Facial and oral manifestations of leprosy: an evaluation one hundred and four cases. J Oral Med 1987: 42: 143-149. 156. Schiodt M, Greenspan D, Daniels TE, Greenspan JS. Clinical and histologic spectrum of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1987: 64: 716-720. 157. Schirm J, Mulkens PS. Bell’s palsy and herpes simplex virus. APMIS 1997: 105: 815-823. 158. Schmidt-Westhausen A, Fehrenbach FJ, Reichart PA. Oral Enterobacteriaceue in patients with HIV infection. J Oral Pathol Med 1990: 19: 229-231. 159. Sciubba JJ. Oral aspects of sexually-transmitted diseases. Ann Dent 1978: 37: 1-7. 160. Scott DA, Coulter WA, Biagioni PA, O’Neill H, Lamey P-J. Detection of herpes simplex virus type 1 shedding in the oral cavity by polymerase chain reaction and enzymelinked immunosorbent assay at the prodromal stage of recrudescent herpes labialis. J Oral Pathol Med 1997: 26: 305-309. 161. SculIy C. Infectious diseases: review of the literature. In: Millard HD, Mason DR, ed. 2nd World Workshop on Oral Medicine. Ann Arbor: University of Michigan, 1995:3:7-16. 162. Shelley WB, Hashim M, Shelley ED. Acyclovir in the treatment of hand-foot-and-mouth disease. Cutis 1996: 57: 232-234. 163. Siege1 MA. Syphilis and gonorrhea. Dent Clin North Am 1996: 40: 369-383. 164. Slater LN, Welch DF, Min Kw. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med 1992: 152: 602-606. 165. Smego RA. Actinomycosis. In: Hoeprich PD, Jordan MC, Ronald AR, ed. Infectious diseases. 5th edn. Philadelphia: Lippincott, 1994: 493497. 166. Speight PM, Fletcher CDM. Epithelioid angiomatosis affecting the oral cavity as a first sign of HlV infection. Br Dent J 1991: 171: 367-370. 167. Stark CA, Adamsson I, Edlund C, Sjosted S, Seesalu R, Wikstrom B, Nord CE. Effects of omeprazole and amoxicillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother 1996: 38: 927-939. 168. Steeper TA, Horwitz CA, Ablashi DV, Salahuddin SK, Saxingcr C, Saltzman R, Schwartz B. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalus. Am J Clin Pathol 1990: 93: 776-783. 169. Steiner I, Kennedy PGE. Herpes simplex virus latent infection in the nervous system. J Neurovirol 1995: 1: 19-29. 170. Steiner I. Human herpes viruses latent infection in the nervous system. Jmmunol Rev 1996: 152: 157-173. 171. Stoler MH, Bonfiglio TA, Steigbigel RT, Pereira M. An atypical subcutaneous infection associated with acquired 123 Rivera-Hidalgo & Stanford immune deficiency syndrome. Am J Clin Pathol 1983: 80: 7 14-71 8. 172. Szaniawski WK, Don PC, Bitterman SR, Schachner JR. Epitheloid angiomatosis in patients with AIDS. J Am Acad Dermatol 1990: 23: 41-48. 173. Takahashi Y, Yamada M, Nakamura J, Tsukasaki T, Padilla J, Kitamura T, Yoshida M, Nii S. Transmission of herpesvirus 7 through multigenerational families in the same household. Pediatr Infect Dis J 1997: 16: 975-978. 174. Takkal AM, Ionescu G, Becker JH. Noma (cancrum oris) associated with Kwashiorkor: a case report and review of the literature. Acta Chir Belg 1996: 96: 179-181. 175. TB diagnosis: new test gives 48-hour result. AIDS Treatment News 1992: 16l(October 16): 1. 176. Tramont EC. Treponerna pallidurn (syphilis). In: Mandell GL, Douglas RG, Bennett JE, ed. Principles of infectious disease. 3rd edn. New York Churchill Livingston, 1990: 1794-1808. 177. Qldesley WR. Infections of the oral mucosa. Br Dent J 1973: 135: 449-455. 178. Veenstra J, van Prag RM, Krol A, Wertheim van Dillem PM, Weigel HM, Schellekens PT, Lange JM, Coutinho RA, van der Meer JT. Complications of varicella zoster virus reactivation in HIV-infected homosexual men. AIDS 1996: 10: 393-399. 179. Vesper M, Riethdorf S, Christoph E, Ruthke A. Schmelzle R, Loning T. Detection of human papillomavirus ( H V P ) DNA in oral manifestation of lichen planus. Mund Kiefer Gesichtschir 1997: 1: 146149. 180. Vidimos AT, Camisa C. Tongue and cheek oral lesions in pityriasis rosea. Cutis 1992: 50: 276-280. 181. Volpe F, Schwimmer A, Barr C. Oral manifestation of disseminated Mycobacterium avium intracellulare in a patient with AIDS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1985: 60: 567-570. 182. Ward KA, Napier SS, Winter PC, Maw RD, Dinsmore W. Detection of human papilloma virus DNA sequences in oral squamous cell papillomas by the polymerase chain reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995: 80: 63-66. 183. Watkins W,Richmond AS, Langstein IM. Nonhealing extraction site due to Actinornycetes naeslundii in patient with AIDS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1991: 71: 675-677. 184. Weg JG. Tuberculosis and other mycobacterial diseases. Barrier 1988: 3: 1-7. 124 185. Weiner GM. Tuberculous parotitis: limiting the role of surgery. J Laryngol Otol 1996: 110: 96-97. 186. Weisner PJ, Tronca E, Bonin P, Pedersen AHB, Holmes KK. Clinical spectrum of pharyngeal gonococcol infection. N Engl J Med 1973: 288: 181-185. 187. Welch DF, Picket DA, Slater LN, Steigerwalt AG, Brenner DJ. Rochalimaea hensalae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol 1991: 30: 275-280. 188. Wen S, Tsuji T, Li X, Mizugaki Y, Hayatsu Y, Shinozaki E Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 1997: 17: 307-211. 189. West RW, Thompson JR. Modeling the impact of HIV on the spread of tuberculosis in the United States. Math Biosci 1997: 143: 35-60. 190. Yadav M, Chandrashekran A, Vasudevan DM, Ablashi DV Frequent detection of human herpesvirus 6 in oral carcinoma. J Natl Cancer Inst 1994: 86: 1792-1794. 191. Yadav M, Arivanathan M, Kumar S. HHV-6 antigen and viral DNA detected in cervical cells from archived tissue using histochemical staining and hybridization. Clin Diagn Virol 1996: 7: 23-33. 92. Yadav M, Arivanathan M, Chandrashekran A, Tan BS, Hashim BY. Human herpesvirus-6 (HHV-6) DNA and virus-encoded antigen in oral lesions. J Oral Pathol Med 1997: 26: 393-401. 93. Yadav M, Nambiar S, Khoo Sl? Yaacob HB. Detection of human herpesvirus 7 in salivary glands. Arch Oral Biol 1997: 42: 559-567. 194. Yeager BA, Hoxie J, Weisman RA, Greenberg MS, Bilaniul LT. Actinomycosis in acquired immunodeficiency syndrome-related complex. Arch Otolaryngol Head Neck Surg 1986: 112: 1293-1295. 195. Yoshikawa T, Hill JM, Stanberry LR, Bourne N, Kurawadwala JFj Kause PR. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med 1996: 184: 659-664. 196. Young EJ, Chafizadeh E, Oliveira VL, Genta RM. Disseminated herpesvirus infection during pregnancy. Clin Infect Dis 1996: 22: 51-58. 197. Zeuss MS, Miller CS, White DK. In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1991: 71: 714-720.